Cartalax Review: Faster Healing Than BPC-157?

·26 min·2 clips

Hunter Williams injected Cartilax into his sore wrist and claims the pain vanished in just 20 minutes.

Hunter Williams introduces Cartilax as an injectable cartilage bioregulator peptide originally developed in Russia. He explains these bioregulators are amino acid sequences modeled after collagen, designed to modulate tissue function and bring it into homeostasis. Hunter shares his personal guinea pig approach, ordering them to compile dosing data. He recounts a specific experiment where, after a gym session left both wrists sore, he injected 2mg of Cartilax into one wrist. He claims within 20 minutes, he had full range of motion and the pain was gone, contrasting this with BPC-157 and TB500 which he says take days. Later in the week, he tested it on a back muscle spasm from hack squats, with similar rapid relief. Based on this, he posits Cartilax could replace or complement BPC-157. The episode then shifts to an educational presentation. Hunter explains Cartilax is a synthetic tripeptide of alanine, glutamic acid, and aspartic acid. Its mechanism involves acting as a gene expression regulator, upregulating repair processes like IGF-1 and downregulating destructive ones like inflammation. It targets fibroblast-like cells in cartilage, skin, and connective tissue. He details its medical applications from Russian use: managing degenerative joint diseases like osteoarthritis, improving bone density in osteoporosis, aiding post-operative rehab, and reducing inflammation in conditions like rheumatoid arthritis. It's also used preventatively for age-related joint deterioration or by athletes for recovery. Hunter reviews scientific research, citing a 2016 study on human skin fibroblasts showing enhanced proliferation and reduced apoptosis, a 2015 experiment on aged kidney tissues, and a 2020 study on aging mesenchymal stem cells where Cartilax upregulated IGF-1 and NF-kappa-B. A 2023 review noted its chondroprotective potential in osteoarthritis models. He mentions sparse animal data but references a Russian patent. A clinical study involved patients with knee osteoarthritis and spinal issues taking oral Cartilax capsules, showing pain reduction and improved mobility with no side effects. Hunter emphasizes the safety profile, noting it's metabolized into amino acids without liver toxicity. He provides dosing protocols: 1mg for 10 days every 4-6 months for preventative maintenance, 2mg for 20 days for therapeutic support, and 2mg for 30-60 days for severe cases. He concludes by calling Cartilax revolutionary in his experience, cheap relative to other peptides, and potentially not banned for athletes as it's just amino acids. He encourages listener experimentation and feedback.

As heard by us

A direct Cartilax review centered on self-experimentation, Russian use, and a pointed BPC comparison.

Cartilax is presented as an injectable cartilage bioregulator for the musculoskeletal system, with Hunter Williams making the case through self-experimentation and a sharp comparison: he says it brought him more immediate benefit than BPC.

Read the full review in PlayNext →

Why you'd press play

Curious whether Cartilax belongs in your recovery rabbit hole? Start here, with Hunter Williams making a confident case from self-experimentation and Russian-use references.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Hunter Williams Podcast